XML 100 R90.htm IDEA: XBRL DOCUMENT v3.25.1
Equity - Earnings Per Share ("EPS") (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Basic    
Net income attributable to common stockholders $ 30,438 $ 57,873
Net income attributable to common stockholders and noncontrolling interest $ 30,438 $ 57,873
Weighted average shares outstanding (in shares) 190,060,776 188,710,390
Weighted average shares outstanding (in shares) 190,060,776 188,710,390
Net income per common share (in dollars per share) $ 0.16 $ 0.31
Diluted    
Net income attributable to common stockholders $ 30,438 $ 57,873
Net income attributable to noncontrolling interest 2,602 4,997
Interest expense on convertible notes 0 6,084
Net income attributable to common stockholders and noncontrolling interest $ 33,040 $ 68,954
Weighted average shares outstanding (in shares) 190,060,776 188,710,390
Dilutive effect of OP Units (in shares) 16,249,284 16,293,589
Dilutive effect of convertible notes (in shares) 0 17,414,547
Dilutive effect of RSUs (in shares) 552,260 507,550
Weighted average shares outstanding (in shares) 206,862,320 222,926,076
Net income per common share (in dollars per share) $ 0.16 $ 0.31
Interest expense $ 6,100  
Convertible senior unsecured notes    
Diluted    
Anti-dilutive shares (in shares) 17,616,593  
Convertible senior unsecured notes    
Diluted    
Interest expense $ 6,100 $ 6,100
Mr. Ivan Kaufman | Performance-based restricted stock    
Diluted    
Vesting period (in years) 4 years